Potential UK Access Pathways Once approved, UK access may follow several routes: NHS specialist weight-management pathways diabetes and metabolic clinics private UK weight-loss clinics licensed prescribers online medical services via regulated telehealth Because the retatrutide peptide targets three metabolic pathways, NHS evaluation may prioritize individuals with severe obesity or strong medical need
Li W, Chen Y, Zhang X, et al
Comparing GLP-1 Weight Loss Medications Potential Side Effects of GLP-1 Medications Common side effects include: Nausea, bloating, or diarrhoea Fatigue or headaches Constipation during dose escalation Rarely: pancreatitis or gallbladder inflammation Most symptoms improve over time
Understanding these considerations can help you establish a sustainable routine that maximises both efficacy and adherence
GLP-1 Drugs Survey Report: What Employers Are and Arent Covering in 2026
This does not mean the product does not work